Exact Sciences (NASDAQ: EXAS) shares are trading lower on Wednesday after the company reported its fourth-quarter earnings.
The company also entered into an .
UK variant of coronavirus confirmed to be in Arizona, health officials confirm
Its scientific name is B.1.1.7., but it is also known as the UK variant of the COVID-19 virus.
By: abc15.com staff, Scripps National
Posted at 11:24 AM, Jan 29, 2021
and last updated 2021-01-30 19:17:10-05
PHOENIX â A variant of coronavirus first spotted in the United Kingdom has made its way to Arizona, health officials confirmed late Friday.
Sources initially alerted ABC15 Friday morning that the variant, which has been shown to spread more easily from person to person, had been detected in our state and that officials were in contact with the Centers for Disease Control and Prevention about its arrival.
Study offers a differentiated patient-specific solution in minimal residual disease testing
Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has acquired a worldwide exclusive license to the proprietary TARDIS technology from the Translational Genomics Research Institute (TGen), an affiliate of City of Hope. This compelling and technically distinct approach will help expand Exact Sciences leadership in precision oncology and offers a differentiated patient-specific solution in minimal residual disease testing.
Analysis of DNA shed into a patient s blood stream can provide a noninvasive means of detecting the presence of a tumor. Patients who have undergone initial treatment may only have small amounts of tumor DNA in their blood, which can be difficult to detect with conventional technology. TARDIS was developed to be highly sensitive and customizable for each patient, including those with only a trace amount of tumor remaining following surgery or other localized treat
Specific genetic target could help explain the variation in COVID-19 effects
The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has identified a specific genetic target that could help explain the tremendous variation in how sick those infected with COVID-19 become.
The study results, recently published in the journal
mSphere, describe a molecule made from DNA miR1307 as a potential dimmer switch that may influence the severity of the disease; why some infected with SARS-CoV-2, the virus that causes COVID-19, have mild or even no symptoms, while others become seriously ill or die.
Led by Nicholas Schork, Ph.D., a Distinguished Professor and Director of TGen s Quantitative Medicine and Systems Biology Division, researchers identified miR1307 by comparing the genetic elements of SARS-Cov-2 with seven other human coronaviruses, some of which merely cause common colds. In addition, they examined the genomes of coronavirus strains known to infect